Abstract

BackgroundDisease named entity recognition (NER) plays an important role in biomedical research. There are a significant number of challenging issues to be addressed; among these, the identification of rare diseases and complex disease names and the problem of tagging inconsistency (i.e., if an entity is tagged differently in a document) are attracting substantial research attention. MethodsWe propose a new neural network method named Dic-Att-BiLSTM-CRF (DABLC) for disease NER. DABLC applies an efficient exact string matching method to match disease entities with a disease dictionary; here, the dictionary is constructed based on the Disease Ontology. Furthermore, DABLC constructs a dictionary attention layer by incorporating a disease dictionary matching method and document-level attention mechanism. Finally, a bidirectional long short-term memory network and conditional random field (BiLSTM-CRF) with a dictionary attention layer is proposed to combine the disease dictionary to develop disease NER. ResultsExtensive experiments are conducted on two widely-used corpora: the NCBI disease corpus and the BioCreative V CDR corpus. We apply each test on 10 executions of each model, with a 95% confidence interval. DABLC achieves the highest F1 scores (NCBI: Precision = 0.883, Recall = 0.89, F1 = 0.886; BioCreative V CDR: Precision = 0.891, Recall = 0.875, F1 = 0.883), outperforming the state-of-the-art methods. ConclusionDABLC combines the advantages of both external dictionary resources and deep attention neural networks. This aids the identification of rare diseases and complex disease names; moreover, it reduces the impact of tagging inconsistency. Special disease NER and deep learning models addressing long sentences are noteworthy areas for future examination.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.